VANCUITY Trademark

Trademark Overview


On Thursday, April 19, 2018, a trademark application was filed for VANCUITY with the United States Patent and Trademark Office. The USPTO has given the VANCUITY trademark a serial number of 79233562. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, June 20, 2025. This trademark is owned by NOVARTIS AG. The VANCUITY trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; [ inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; ] pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for th...
vancuity

General Information


Serial Number79233562
Word MarkVANCUITY
Filing DateThursday, April 19, 2018
Status709 - CANCELLED - SECTION 71
Status DateFriday, June 20, 2025
Registration Number5619787
Registration DateTuesday, December 4, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 18, 2018

Trademark Statements


Certificate of Correction for RegistrationIn the Statement, class 5 has been corrected per the Restriction dated 3/28/2019, and per the Fnote dated 5/23/2019.
Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; [ inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; ] pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases [ ; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma ]

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, June 20, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Saturday, June 16, 2018APPLICATION FILING RECEIPT MAILED
Thursday, June 7, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, June 11, 2018LIMITATION FROM ORIGINAL APPLICATION ENTERED
Tuesday, June 12, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 19, 2018ASSIGNED TO EXAMINER
Tuesday, June 19, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 4, 2018NOTICE OF PUBLICATION
Thursday, July 5, 2018WITHDRAWN FROM PUB - OG REVIEW QUERY
Wednesday, August 29, 2018NOTICE OF PUBLICATION
Wednesday, September 5, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 5, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, September 18, 2018PUBLISHED FOR OPPOSITION
Friday, September 21, 2018NOTIFICATION PROCESSED BY IB
Tuesday, December 4, 2018REGISTERED-PRINCIPAL REGISTER
Thursday, January 3, 2019GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Wednesday, January 16, 2019FINAL DISPOSITION PROCESSED
Wednesday, January 16, 2019FINAL DISPOSITION NOTICE SENT TO IB
Friday, February 1, 2019NOTIFICATION PROCESSED BY IB
Friday, March 29, 2019LIMITATION OF GOODS RECEIVED FROM IB
Thursday, May 23, 2019CORRECTION UNDER SECTION 7 - PROCESSED
Friday, June 20, 2025CANCELLED SECTION 71
Thursday, May 23, 2019LIMITATION FROM THE IB EXAMINED AND ENTERED